The Clinical Values of Serum Markers in the Early Prediction of Hepatocellular Carcinoma

被引：6

作者：

Li, Bo ^{[1
]}

Li, Boan ^{[1
]}

Guo, Tongsheng ^{[1
]}

Sun, Zhiqiang ^{[1
]}

Li, Xiaohan ^{[1
,2
]}

Li, Xiaoxi ^{[1
]}

Wang, Han ^{[1
]}

Chen, Weijiao ^{[1
]}

Chen, Peng ^{[1
]}

Mao, Yuanli ^{[1
,2
]}

机构：

[1] 302 Mil Hosp, Ctr Clin Lab, Beijing, Peoples R China

[2] Med Univ PLA, Grad Student Team, Beijing, Peoples R China

来源：

BIOMED RESEARCH INTERNATIONAL | 2017年 / 2017卷

关键词：

ALPHA-FETOPROTEIN; EXPRESSION; BIOMARKERS; DIAGNOSIS; PROTEIN; GP73; ALPHA-FETOPROTEIN-L3;

D O I：

10.1155/2017/5358615

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

The early prediction values of diagnostic markers for hepatocellular carcinoma (HCC) are still unclear at present. This study evaluated the prediction value of ten serum markers in HCC. A total of 109 cases of hepatic cirrhosis patients were followed up for 36 months and the relationship between the lifetime risk of developing HCC and levels of serum markers was analyzed. 31.2 (34/109) percent of hepatic cirrhosis patients developed HCC during the study's timeframe. Higher alpha-fetoprotein (AFP), alpha-fetoprotein-L3 (AFP-L3), alanine aminotransferase (ALT), and AFP-L3/AFP ratio levels are potential risk factors for malignization in hepatic cirrhosis patients (RR = 2.99, 2.92, 2.72, and 2.34); serum Golgi protein 73 (GP73) level of hepatic cirrhosis patients decreased significantly after developing HCC (t = 2.212; p = 0.041). The detection of ALT, AFP, AFP-L3, and GP73 has a certain guiding significance to predict the risk of HCC in hepatic cirrhosis patients.

引用

页数：11

共 28 条

[1] Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005 [J].

Altekruse, Sean F. ;

McGlynn, Katherine A. ;

Reichman, Marsha E. .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (09) :1485-1491

[2]

Bao Yong-xing, 2013, Zhonghua Zhong Liu Za Zhi, V35, P505

[3] Management of Hepatocellular Carcinoma: An Update [J].

Bruix, Jordi ;

Sherman, Morris .

HEPATOLOGY, 2011, 53 (03) :1020-1022

[4] Albumin mRNA in plasma predicts post-transplant recurrence of patients with hepatocellular carcinoma [J].

Cheung, Siu Tim ;

Fan, Sheung Tat ;

Lee, Yuk Ting ;

Chow, Jeremy P. ;

Ng, Irene O. ;

Fong, Daniel Y. ;

Lo, Chung Mau .

TRANSPLANTATION, 2008, 85 (01) :81-87

[5]

Chinese Society of Hepatology and Chinese Society of Infectious Diseases, 2004, ZHONGHUA YU FANG YI, V38, P10

[6]

Chinese Society of Hepatology Chinese Medical Association and Chinese Society of Infectious Diseases Chinese Medical Association, 2011, Chin J Exp Clin Infect Dis, V5, P79

[7] α-fetoprotein and ultrasonography screening for hepatocellular carcinoma [J].